{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T03:54:04Z","timestamp":1775966044528,"version":"3.50.1"},"reference-count":51,"publisher":"American Institute of Mathematical Sciences (AIMS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MBE"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3934\/mbe.2016038","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T15:47:01Z","timestamp":1472485621000},"page":"1185-1206","source":"Crossref","is-referenced-by-count":22,"title":["Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases"],"prefix":"10.3934","volume":"13","author":[{"given":"Ami B.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna A.","family":"Rejniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana L.","family":"Gevertz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2321","reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12033-010-9321-2","article-title":"Multiple drug resistance mechanisms in cancer,","volume":"46","author":"B. Baguley","year":"2010","journal-title":"Mol. Biotechnol.<\/em>"},{"key":"2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jtbi.2013.06.036","article-title":"Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers,","volume":"335","author":"S. Benzekry","year":"2013","journal-title":"Journal of Theoretical Biology<\/em>"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00747","article-title":"Evolutionary dynamics of cancer in response to targeted combination therapy,","volume":"2","author":"I. Bozic","year":"2013","journal-title":"eLife<\/em>"},{"key":"4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12609-014-0143-2","article-title":"Understanding drug resistance in breast cancer with mathematical oncology,","volume":"6","author":"T. Brocato","year":"2014","journal-title":"Curr. Breast Cancer Rep.<\/em>"},{"key":"5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.lungcan.2006.08.013","article-title":"Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: Phase II trial,","volume":"54","author":"L. Buffoni","year":"2006","journal-title":"Lung Cancer<\/em>"},{"key":"6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jcp.1041510220","article-title":"Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration and extracellular pH,","volume":"151","author":"J. Casciari","year":"1992","journal-title":"J. Cellular Physiol.<\/em>"},{"key":"7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF02459682","article-title":"A stochastic model for the origin and treatment of tumors containing drug-resistant cells,","volume":"48","author":"A. Coldman","year":"1986","journal-title":"Bull. Math. Biol.<\/em>"},{"key":"8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/emph\/eov006","article-title":"Divergent and convergent evolution in metastases suggest treatment strategies based on specific metastatic sites,","volume":"2015","author":"J. Cunningham","year":"2015","journal-title":"Evolution"},{"key":"9","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1021\/mp2002279","article-title":"Evolutionary dynamics in cancer therapy,","volume":"8","author":"J. Cunningham","year":"2011","journal-title":"Mol. Pharm.<\/em>"},{"key":"10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1158\/1535-7163.MCT-11-0058","article-title":"Chemotherapy dosing schedule influences drug resistance development in ovarian cancer,","volume":"10","author":"R. De Souza","year":"2011","journal-title":"Mol. Cancer Ther.<\/em>"},{"key":"11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1593\/neo.101174","article-title":"Tumor that acquire resistance to low-dose metronomic cyclophosphamide retain sensitivity to maximum tolerated dose cyclophosphamide,","volume":"13","author":"U. Emmenegger","year":"2011","journal-title":"Neoplasia<\/em>"},{"key":"12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/eva.12019","article-title":"Cancer as a moving target: Understanding the composition and rebound growth kinetics of recurrent tumors,","volume":"6","author":"J. Foo","year":"2013","journal-title":"Evol. Appl.<\/em>"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000557","article-title":"Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies,","volume":"5","author":"J. Foo","year":"2009","journal-title":"PLoS Comput. Biol.<\/em>"},{"key":"14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jtbi.2009.11.022","article-title":"Evolution of resistance to anti-cancer therapy during general dosing schedules,","volume":"263","author":"J. Foo","year":"2010","journal-title":"J. Theor. Biol.<\/em>"},{"key":"15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jtbi.2014.02.025","article-title":"Evolution of acquired resistance to anti-cancer therapy,","volume":"355","author":"J. Foo","year":"2014","journal-title":"J. Theor. Biol.<\/em>"},{"key":"16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/jcp.1041240323","article-title":"A reduction in the in situ rates of oxygen and glucose consumption of cells in EMT6\/Ro spheroids during growth,","volume":"124","author":"J. Freyer","year":"1985","journal-title":"J. Cellular Physiol.<\/em>"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004142","article-title":"Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy,","volume":"11","author":"F. Fu","year":"2015","journal-title":"PLoS Comput. Biol.<\/em>"},{"key":"18","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1158\/0008-5472.CAN-08-3658","article-title":"Adaptive therapy,","volume":"69","author":"R. Gatenby","year":"2009","journal-title":"Cancer Res.<\/em>"},{"key":"19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2782-1_1","article-title":"Emergence of anti-cancer drug resistance: Exploring the importance of the microenvironmental niche via a spatial model,","author":"J. Gevertz","year":"2015","journal-title":"in Applications of Dynamical Systems in Biology and Medicine<\/em> (eds. T. Jackson and A. Radunskaya)"},{"key":"20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11538-014-9936-8","article-title":"The impact of cell density and mutations in a model of multidrug resistance in solid tumors,","volume":"76","author":"J. Greene","year":"2014","journal-title":"Bull. Math. Biol.<\/em>"},{"key":"21","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1109\/TBME.2013.2280189","article-title":"Mathematical modeling of tumor growth, drug- resistance, toxicity, and optimal therapy design,","volume":"61","author":"M. Hadjiandreou","year":"2013","journal-title":"IEEE Trans. Biomed. Eng.<\/em>"},{"key":"22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1172\/JCI9872","article-title":"Less is more, regularly: Metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice,","volume":"105","author":"D. Hanahan","year":"2000","journal-title":"The Journal of Clinical Investigations<\/em>"},{"key":"23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0025-5564(99)00062-0","article-title":"A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy,","volume":"164","author":"T. Jackson","year":"2000","journal-title":"Math. Biosci.<\/em>"},{"key":"24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nrc1650","article-title":"Repopulation of cancer cells during therapy: An important cause of treatment failure,","volume":"5","author":"J. Kim","year":"2005","journal-title":"Nat. Rev. Cancer<\/em>"},{"key":"25","doi-asserted-by":"publisher","first-page":"9714","DOI":"10.1073\/pnas.0501870102","article-title":"Drug resistance in cancer: Principles of emergence and prevention,","volume":"102","author":"N. Komarova","year":"2005","journal-title":"Proc. Natl. Acad. Sci.<\/em>"},{"key":"26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.tpb.2007.08.003","article-title":"Stochastic modeling of cellular colonies with quiescence: An application to drug resistance in cancer,","volume":"72","author":"N. Komarova","year":"2007","journal-title":"Theor. Popul. Biol.<\/em>"},{"key":"27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.drup.2012.01.003","article-title":"The dynamics of drug resistance: A mathematical perspective,","volume":"15","author":"O. Lavi","year":"2012","journal-title":"Drug Resist. Update<\/em>"},{"key":"28","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1158\/0008-5472.CAN-13-1768","article-title":"The role of cell density and intratumoral heterogeneity in multidrug resistance,","volume":"73","author":"O. Lavi","year":"2013","journal-title":"Cancer Res.<\/em>"},{"key":"29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3934\/mbe.2015.12.1257","article-title":"Dynamics and control of a mathematical model for metronomic chemotherapy,","volume":"12","author":"U. Ledzewicz","year":"2015","journal-title":"Mathematical Biosciences and Engineering<\/em>"},{"key":"30","first-page":"129","article-title":"Drug resistance in cancer chemotherapy as an optimal control problem,","volume":"6","author":"U. Ledzewicz","year":"2006","journal-title":"Discret. Contin. Dyn-B<\/em>"},{"key":"31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3934\/mbe.2013.10.803","article-title":"On the MTD paradigm and optimal control for multi-drug cancer chemotherapy,","volume":"10","author":"U. Ledzewicz","year":"2013","journal-title":"Math. Biosci. Eng.<\/em>"},{"key":"32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11538-014-0046-4","article-title":"Modeling effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors,","volume":"77","author":"A. Lorz","year":"2015","journal-title":"Bull. Math. Biol.<\/em>"},{"key":"33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1051\/m2an\/2012031","article-title":"Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies,","volume":"47","author":"A. Lorz","year":"2013","journal-title":"ESAIM: Math. Model. Num. Anal.<\/em>"},{"key":"34","article-title":"Metronomics as maintenance treatment in oncology: Time for chemo-switch,","volume":"4","author":"V. Malik P.S.and Raina","year":"2014","journal-title":"Front. Oncol.<\/em>"},{"key":"35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.0960-7722.2001.00216.x","article-title":"Cell migration and organization in the intestinal crypt using a lattice-free model,","volume":"34","author":"F. Meineke","year":"2001","journal-title":"Cell Prolif.<\/em>"},{"key":"36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10441-015-9248-x","article-title":"The effect of intrinsic and acquired resistances on chemotherapy effectiveness,","volume":"63","author":"S. Menchon","year":"2015","journal-title":"Acta Biother.<\/em>"},{"key":"37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7243\/2049-7962-1-32","article-title":"Metronomic anti-cancer therapy - an ongoing treatment option for advanced cancer patients,","volume":"1","author":"K. Mross","year":"2012","journal-title":"Journal of Cancer Therapeutics & Research<\/em>"},{"key":"38","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1021\/mp200270v","article-title":"Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer,","volume":"8","author":"S. Mumenthaler","year":"2011","journal-title":"Mol. Pharm.<\/em>"},{"key":"39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3747\/co.v16i2.420","article-title":"Metronomic chemotherapy: Changing the paradigm that more is better,","volume":"16","author":"O. G. Scharovsky","year":"2012","journal-title":"Current Oncology<\/em>"},{"key":"40","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/9\/6\/065007","article-title":"Cancer treatment as a game: Integrating evolutionary game theory into the optimal control of chemotherapy,","volume":"9","author":"P. Orlando","year":"2012","journal-title":"Phys. Biol.<\/em>"},{"key":"41","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1200\/JCO.2005.07.093","article-title":"A multitargeted, metronomic, and maximum-tolerated dose \"chemo-switch\" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer,","volume":"23","author":"K. Pietras","year":"2005","journal-title":"J. Clinical Oncology<\/em>"},{"key":"42","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/bjc.2015.146","article-title":"Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: 'What does not kill me strengthens me',","volume":"112","author":"A. Pisco","year":"2015","journal-title":"Br. J. Cancer<\/em>"},{"key":"43","article-title":"Investigating the development of chemotherapeutic drug resistance in cancer: A multiscale computational study,","author":"G. Powathil","journal-title":"Molecular Oncology<\/em>"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6150-5-25","article-title":"A theoretical quantitative model for evolution of cancer chemotherapy resistance,","volume":"5","author":"A. Silva","year":"2010","journal-title":"Biol. Direct.<\/em>"},{"key":"46","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment,","volume":"99","author":"O. Tr\u00e9dan","year":"2007","journal-title":"J. Natl. Cancer Inst.<\/em>"},{"key":"47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/adt.2005.3.525","article-title":"Assessing the minimum number of data points required for accurate IC50 determination,","volume":"3","author":"R. Turner","year":"2005","journal-title":"Assay Drug Dev Technol.<\/em>"},{"key":"48","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/ijc.28259","article-title":"Motronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells,","volume":"133","author":"M. Vives","year":"2013","journal-title":"International Journal of Cancer<\/em>"},{"key":"49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nature14971","article-title":"A spatial model predicts that dispersal and cell turnover limit intratumor heterogeneity,","volume":"525","author":"B. Waclaw","year":"2015","journal-title":"Nature<\/em>"},{"key":"50","doi-asserted-by":"publisher","first-page":"16103","DOI":"10.1073\/pnas.1314385110","article-title":"Cell motility and drug gradients in the emergence of resistance to chemotherapy,","volume":"110","author":"A. Wu","year":"2013","journal-title":"Proc. Natl. Acad. Sci.<\/em>"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00028","article-title":"Mechanisms and insights into drug resistance in cancer,","volume":"4","author":"H. Zahreddine","year":"2013","journal-title":"Front. Pharmacol.<\/em>"}],"container-title":["Mathematical Biosciences and Engineering"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.aimsciences.org\/journals\/displayArticlesnew.jsp?paperID=12883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T03:56:15Z","timestamp":1657166175000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.aimsciences.org\/journals\/displayArticlesnew.jsp?paperID=12883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.3934\/mbe.2016038","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/042408","asserted-by":"object"}]},"ISSN":["1551-0018"],"issn-type":[{"value":"1551-0018","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}